Research projects

Grant awarded to open SIOPEN High-Risk Neuroblastoma Clinical Trial 2 across the UK in 2021

Grant Award - High-Risk Neuroblastoma Clinical Trial 2 Read more

Lorlatinib (PF-06463922) : Third-generation ALK inhibitor

This exciting new clinical trial sees 17 transatlantic centres in the UK, USA and Europe, recruiting patients simultaneously for an innovative new third-generation ALK-inhibitor agent lorlatinib (PF-06463922). Read more

National Neuroblastoma Genetics Reference Centre

The National Neuroblastoma Genetics Reference Centre aims to provide a comprehensive service genetic characterisation of all neuroblastoma tumours at diagnosis and a subset at relapse. Read more

Biomarker evaluation of neuroblastoma mRNAs in children enrolled in the BEACON trial

In this study, blood and bone marrow samples from 120 children treated in the BEACON-Neuroblastoma trial will be collected in order to analyse levels of neuroblastoma mRNAs Read more

MiNivAn : Phase I study of I-131 MIBG, nivolumab and ch14.18/CHO

MiNivAn aims to improve the cure rate of children with relapsed or refractory neuroblastoma by combining targeted radiotherapy (I-131 MIBG) with the antibodies anti-GD2 (ch14.18/CHO) and anti-PD1 (nivolumab). Read more

Neuroblastoma Senior Trials Coordinator

Solving Kids’ Cancer funds a dedicated Senior Trials Coordinator for Neuroblastoma within the Children’s Cancer Trials Team (CCTU) of the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham. Read more

PTPP – ITCC-P4 Collaboration

Bringing together American NCI PPTC and European ITCC-P4 paediatric preclinical research consortiums together for the first time ever via the Pediatric Cancer Working Group at the AACR Annual Meeting. Read more

BEACON Immuno (anti-GD2 amendment)

The BEACON study is a chemotherapy and antibody combination trial. Read more

International Neuroblastoma Research Initiative 2018

Solving Kids’ Cancer is leading an international competitive funding call commencing with a Request for Applications (RFA) Read more

International Research Initiative 2019

Solving Kids’ Cancer has issued a joint 2019 International Challenge Grant Call for GBP 500,000 awarded over three years Read more

Latest

COIF Charities Ethical Fund

COIF Charities Ethical Fund - Investment Exclusion List

Inspirational Ollie

To help Ollie and his family reach their target amount, which will enable them to take him to NY for Clinical Trials, in the hope it’ll stop his cancer from returning.

Beauty and the Beard

The challenge is to grow your beard or hair for 3 months to support Solving Kids' Cancer!

Cycling 1000km for Henry the Brave

Henry has high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis. His family are appealing for your help to raise £202,000 by January 2021.

Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

Lily-Mae from Galway, Ireland will be celebrating her 12th birthday this April, but for her parents Judith and Leighton every day is a blessing.

Corey is thriving after neuroblastoma battle

Family donate almost £150,000 to neuroblastoma research

Solving Kids' Cancer welcomes Alexandra Lane to the Board of Trustees

Alexandra Lane was formally voted on and welcomed to our Board of Trustees this week. We are thrilled to welcome Alex to the team.

BEACON study opens in Europe

The much-anticipated BEACON study amendment is now open and recruiting patients.

Steve Richards to step down as Chief Executive

CEO to leave Solving Kids' Cancer after three years in the role.

Solving Kids’ Cancer appoints new Chief Executive Officer

Solving Kids’ Cancer, a national neuroblastoma charity, has appointed Gail Jackson as its new Chief Executive Officer.

Charities fund new clinical trial

Solving Kids’ Cancer, with Neuroblastoma UK, has awarded a grant of £609,762.40 to enable the SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) to open in the UK, it is anticipated to open in early 2021.

First Three Months

Gail Jackson, CEO, launches her blog. Reflecting on personal resilience, our work and joining Solving Kids' Cancer as COVID hit.

Nellie-Rose's Campaign

Nellie-Rose is battling a disease no child should have to. She has high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.

Ewen's Urgent Appeal

Ewen is a happy and restless boy who runs everywhere. He loves trucks, cars and blowing dandelions. But this amazing little boy has had his childhood interrupted by childhood cancer.